Trump's Tariffs Could Impact This Top Growth Stock. Here's Why It's Still a Buy

President Donald Trump's macroeconomic policies are creating significant uncertainty. His decision to impose sweeping tariffs on goods imported into the U.S. could harm the economy and specific corporations in ways that are scaring off investors. Some companies are already factoring the impact of tariffs on their financial results. One of them is Intuitive Surgical (NASDAQ: ISRG), a leader in medical devices. Despite the predicted effect of tariffs on the company's financial results for the rest of the year, the maker of robotic-assisted surgery (RAS) devices still looks like an excellent stock to buy. Here's what investors need to know.The past 18 months have been productive for Intuitive Surgical. Early last year, it earned approval for the fifth generation of its best-known RAS device, the da Vinci system. The launch of this upgraded device exceeded analysts' expectations. It made a meaningful impact on the company's quarterly placement of da Vinci systems. Meanwhile, Intuitive Surgical continues to post strong earnings. In the first quarter, the company's revenue increased to $2.25 billion, a 19% year-over-year rise, driven by a 17% increase in da Vinci procedures. Intuitive Surgical sold 367 da Vinci systems in the period (including 147 of the fifth generation), compared to 313 in the comparable period of the previous fiscal year.It ended the quarter with an installed base of 10,189 systems, 15% higher than the year-ago period. Lastly, Intuitive Surgical's adjusted earnings per share increased to $1.81, a 21% year-over-year rise.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool